JP2024545093A5 - - Google Patents

Info

Publication number
JP2024545093A5
JP2024545093A5 JP2024533994A JP2024533994A JP2024545093A5 JP 2024545093 A5 JP2024545093 A5 JP 2024545093A5 JP 2024533994 A JP2024533994 A JP 2024533994A JP 2024533994 A JP2024533994 A JP 2024533994A JP 2024545093 A5 JP2024545093 A5 JP 2024545093A5
Authority
JP
Japan
Prior art keywords
substituted
independently
nanoparticles
polymer
occurrence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533994A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024545093A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081189 external-priority patent/WO2023108076A1/en
Publication of JP2024545093A publication Critical patent/JP2024545093A/ja
Publication of JP2024545093A5 publication Critical patent/JP2024545093A5/ja
Pending legal-status Critical Current

Links

JP2024533994A 2021-12-08 2022-12-08 細胞および組織に標的化するためのポリ(アミン-co-エステル)ナノ粒子への表面コンジュゲーション Pending JP2024545093A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US202163287410P 2021-12-08 2021-12-08
US63/287,410 2021-12-08
US202163290042P 2021-12-15 2021-12-15
US63/290,042 2021-12-15
US202163292200P 2021-12-21 2021-12-21
US63/292,200 2021-12-21
US202263301942P 2022-01-21 2022-01-21
US63/301,942 2022-01-21
US202263302413P 2022-01-24 2022-01-24
US63/302,413 2022-01-24
US202263418744P 2022-10-24 2022-10-24
US63/418,744 2022-10-24
PCT/US2022/081189 WO2023108076A1 (en) 2021-12-08 2022-12-08 Surface conjugation to poly(amine-co-ester) nanoparticles for targeting to cells and tissues

Publications (2)

Publication Number Publication Date
JP2024545093A JP2024545093A (ja) 2024-12-05
JP2024545093A5 true JP2024545093A5 (cg-RX-API-DMAC7.html) 2025-12-16

Family

ID=85076045

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024534314A Pending JP2025502630A (ja) 2021-12-08 2022-12-08 ナノ粒子免疫原性組成物及びワクチン接種法
JP2024533994A Pending JP2024545093A (ja) 2021-12-08 2022-12-08 細胞および組織に標的化するためのポリ(アミン-co-エステル)ナノ粒子への表面コンジュゲーション

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2024534314A Pending JP2025502630A (ja) 2021-12-08 2022-12-08 ナノ粒子免疫原性組成物及びワクチン接種法

Country Status (5)

Country Link
US (3) US20230172870A1 (cg-RX-API-DMAC7.html)
EP (2) EP4444358A1 (cg-RX-API-DMAC7.html)
JP (2) JP2025502630A (cg-RX-API-DMAC7.html)
CA (2) CA3240407A1 (cg-RX-API-DMAC7.html)
WO (2) WO2023108076A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3183351A1 (en) 2020-06-19 2021-12-23 Yale University Poly(amine-co-ester) polymers with modified end groups and enhanced pulmonary delivery
WO2025101580A1 (en) * 2023-11-06 2025-05-15 Yale University Half-antibodies and other antibody fragments for attachment to degradable polymer nanoparticles
CN119286942B (zh) * 2024-12-12 2025-07-04 中国水产科学研究院南海水产研究所 一种用于水产动物基因编辑的纳米载体及基因编辑方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920003787B1 (ko) 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
US5571711A (en) 1993-06-17 1996-11-05 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors
GB9400411D0 (en) 1994-01-11 1994-03-09 Johnson Matthey Plc Improvements in chemical compounds
US5821122A (en) 1995-06-07 1998-10-13 Inserm (Institute Nat'l De La Sante Et De La Recherche . .) Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
WO2000011947A1 (en) 1998-08-28 2000-03-09 Uropath Pty. Ltd. Method of diagnosis of prostate cancer
US6673545B2 (en) 2000-07-28 2004-01-06 Incyte Corporation Prostate cancer markers
MXPA03000905A (es) 2000-08-02 2003-06-24 Slil Biomedical Corp Compuestos de poliamina ciclicos como tratamiento contra el cancer.
US20030008000A1 (en) * 2001-03-08 2003-01-09 Wong Jonathan P. DNA vaccine using liposome-encapsulated plasmid DNA encoding for hemagglutinin protein of influenza virus
US9241898B2 (en) 2008-03-11 2016-01-26 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
US10487332B2 (en) * 2010-07-06 2019-11-26 Glaxosmithkline Biologicals Sa Immunisation of large mammals with low doses of RNA
US10465042B2 (en) * 2011-12-02 2019-11-05 Yale University Poly(amine-co-ester) nanoparticles and methods of use thereof
US9272043B2 (en) 2011-12-02 2016-03-01 Yale University Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
US10682422B2 (en) * 2014-11-18 2020-06-16 Yale University Formulations for targeted release of agents under low pH conditions and methods of use thereof
JP2019508037A (ja) 2016-02-16 2019-03-28 イェール ユニバーシティーYale Universit 標的化遺伝子編集を増強するための組成物およびその使用方法
US10765638B2 (en) 2017-11-03 2020-09-08 Yale University Particle formulation with polycation complex
US10874737B2 (en) * 2018-06-01 2020-12-29 Iowa State University Research Foundation, Inc. Influenza nanovaccine
US20210189431A1 (en) * 2018-08-10 2021-06-24 Yale University Compositions and methods for embryonic gene editing in vitro
US11814464B2 (en) * 2019-04-29 2023-11-14 Yale University Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof
US12162953B2 (en) * 2019-12-06 2024-12-10 Yale University Enhanced targeting platform
BR112022015666A2 (pt) * 2020-02-14 2022-09-27 Etherna Immunotherapies Nv Vacinas intranasais de mrna
CA3183351A1 (en) * 2020-06-19 2021-12-23 Yale University Poly(amine-co-ester) polymers with modified end groups and enhanced pulmonary delivery
MX2023007574A (es) * 2020-12-22 2023-09-29 CureVac SE "vacuna de arn contra variantes de sars-cov-2.
US20240342271A1 (en) * 2021-08-03 2024-10-17 Bharat Biotech International Limited Synergism of immunogenicity via combined parenteral and mucosal immunization against covid-19

Similar Documents

Publication Publication Date Title
US6221959B1 (en) Polynucleotide compositions
EP1503802B1 (en) Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
Rinkenauer et al. The influence of polymer architecture on in vitro pDNA transfection
US6353055B1 (en) Polynucleotide compositions
US6359054B1 (en) Polynucleotide compositions for intramuscular administration
Neu et al. Recent advances in rational gene transfer vector design based on poly (ethylene imine) and its derivatives
EP1621569B1 (en) Polyethylene glycol/polycation block copolymer
US9051354B2 (en) Protein charge regulator and protein-encapsulating polymer micelle complex
KR20080108153A (ko) 생분해성 양이온 중합체
CA2205486A1 (en) Polynucleotide compositions
JP2023531444A5 (cg-RX-API-DMAC7.html)
JPWO2020116640A1 (ja) 薬物複合体、ポリマー複合体及び薬物送達用組成物
Jin et al. Synthesis and application of spermine-based amphiphilic poly (β-amino ester) s for siRNA delivery
WO2005078084A1 (ja) 2本鎖オリゴ核酸を担持したポリイオンコンプレックスおよびその製造法とそれを含む医薬組成物
WO2001060415A1 (en) Methods and compositions for gene delivery
JPWO2011096408A1 (ja) 複合体微粒子およびその製造方法、ならびに該複合体微粒子を用いた薬学組成物
JP2006067889A (ja) Peoと二本鎖核酸のコンジュゲート
Gebhart et al. Perspectives on polymeric gene delivery
US10858484B2 (en) Biodegradable dendritic structure, methods and uses thereof
CN105705639A (zh) 登革病毒相关的基因特异性siRNA、包含该siRNA的双链寡RNA分子、和包含它们的用于抑制登革病毒复制的组合物
AU2017242657B2 (en) Synthetic compound for improving efficiency of transfection
Xing et al. Polycationic nanoparticles as nonviral vectors employed for gene therapy in vivo
EP1003527A1 (en) Polynucleotide compositions
EP4408998A1 (en) Polymeric nanoparticle genetic vaccines
KR20100001563A (ko) 비-바이러스성 유전자 전달체용 중합체/유전자 복합체